» Articles » PMID: 37394507

Acceptability and Feasibility of Saliva-delivered PCR Coronavirus 2019 Tests for Young Children

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2023 Jul 2
PMID 37394507
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Access to readily available, reliable, and easy-to-use coronavirus disease 2019 (COVID-19) tests remains critical, despite great vaccination progress. Universal back-to-school testing offered at early care and education ([ECE]; ie, preschool) sites to screen for positive cases may help preschoolers safely return to, and stay in, ECE. We examined the acceptability and feasibility of using a quantitative polymerase chain reaction COVID-19 saliva test for young children (n = 227, 54.0% girls: mean age = 52.3 ± 8.1 months) and their caregivers (n = 70 teachers: mean = 36.6 ± 14.7 years; n = 227 parents: mean = 35.5 ± 9.1 years) to mitigate the spread of COVID-19 and reduce days of school and work missed for households with children who test positive.

Methods: Participants were recruited at ECE sites serving low-income communities as part of the Rapid Acceleration of Diagnostic Testing-Underserved Populations Back to Early Care and Education Safely with Sustainability via Active Garden Education project (NCT05178290).

Results: Surveys in English or Spanish administered at testing events to children and caregivers at ECE sites showed child and adult acceptability and feasibility ratings were generally high. More favorable child and parent ratings were positively associated with child age and whether the child was able to produce a saliva sample. Language preference was not associated with any outcomes.

Conclusions: Saliva sampling for COVID-19 at ECE sites is an acceptable strategy as an additional layer of protection for 4- and 5-year-olds; however, alternate testing strategies may be needed for younger children.

Citing Articles

Influence parental- and child-related factors on the acceptance of SARS-CoV-2 test methods in schools and daycare facilities.

Loy J, Kimmig C, Klos S, Wunram H, Langer T, Breitinger E Front Public Health. 2024; 12:1264019.

PMID: 39091535 PMC: 11291219. DOI: 10.3389/fpubh.2024.1264019.


Diagnostic testing preferences can help inform future public health response efforts: Global insights from an international survey.

Salzano L, Narayanan N, Tobik E, Akbarzada S, Wu Y, Megiel S PLOS Glob Public Health. 2024; 4(7):e0003547.

PMID: 39078819 PMC: 11288416. DOI: 10.1371/journal.pgph.0003547.

References
1.
Mackey K, Ayers C, Kondo K, Saha S, Advani S, Young S . Racial and Ethnic Disparities in COVID-19-Related Infections, Hospitalizations, and Deaths : A Systematic Review. Ann Intern Med. 2020; 174(3):362-373. PMC: 7772883. DOI: 10.7326/M20-6306. View

2.
Toomey R, Umana-Taylor A, Williams D, Harvey-Mendoza E, Jahromi L, Updegraff K . Impact of Arizona's SB 1070 immigration law on utilization of health care and public assistance among Mexican-origin adolescent mothers and their mother figures. Am J Public Health. 2013; 104 Suppl 1:S28-34. PMC: 3924594. DOI: 10.2105/AJPH.2013.301655. View

3.
Lieberman-Cribbin W, Tuminello S, Flores R, Taioli E . Disparities in COVID-19 Testing and Positivity in New York City. Am J Prev Med. 2020; 59(3):326-332. PMC: 7316038. DOI: 10.1016/j.amepre.2020.06.005. View

4.
Galanis P, Vraka I, Siskou O, Konstantakopoulou O, Katsiroumpa A, Kaitelidou D . Willingness, refusal and influential factors of parents to vaccinate their children against the COVID-19: A systematic review and meta-analysis. Prev Med. 2022; 157:106994. PMC: 8861629. DOI: 10.1016/j.ypmed.2022.106994. View

5.
Chua P, Shah S, Gui H, Koh J, Somani J, Pang J . Epidemiological and clinical characteristics of non-severe and severe pediatric and adult COVID-19 patients across different geographical regions in the early phase of pandemic: a systematic review and meta-analysis of observational studies. J Investig Med. 2021; 69(7):1287-1296. PMC: 8485127. DOI: 10.1136/jim-2021-001858. View